1.Extraction process optimization and content determination of eight nucleosides from Pheretima guillelmi
Quan-Lin YU ; Xue-Chun WU ; Yi QIU ; Jia-Jia SONG ; Qiao-Ping JIANG ; Chang-Sheng SUN ; Jing-Nan WU ; Cheng-Ke CAI ; Hong-Fei WANG
Chinese Traditional Patent Medicine 2024;46(8):2526-2530
		                        		
		                        			
		                        			AIM To optimize the extraction process for uracil,hypoxanthine,xanthine,uridine,thymine,inosine,guanosine and 2'-deoxyguanosine from Pheretima guillelmi(Michaelsen),and to determine their contents.METHODS With solid-liquid ratio,ultrasonic time and ultrasonic temperature as influencing factors,contents of hypoxanthine and total nucleosides as evaluation indices,the extraction process was optimized by orthogonal test.HPLC was adopted in the content determination of varioud nucleosides,the analysis was performed on a 30℃thermostatic Agilent C18 column(4.6 mm×250 mm,5 μm),with the mobile phase comprising of methanol-water flowing at 1 mL/min in a gradient elution manner,and the detection wavelength was set at 260 nm.RESULTS The optimal conditions were determined to be 1∶250 for solid-liquid ratio,60 min for ultrasonic time,and 60℃for ultrasonic temperature.Eight nucleosides showed good linear relationships within their own ranges(R2>0.999 0),whose average recoveries were 99.11%-103.27%with the RSDs of 0.85%-2.89%.CONCLUSION This stable and reliable method can be used for the extraction and content determination of nucleosides from P.guillelmi.
		                        		
		                        		
		                        		
		                        	
2.Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation with Decitabine-containing Regimen in Myelodysplastic Syndromes and Myelodysplastic Syndromes Transformed Acute Myeloid Leukemia.
Yu-Xin WANG ; Yao SUN ; Jing XIE ; Na LIU ; Jiang-Wei HU ; Zhuo-Qing QIAO ; San-Chun LAN ; Long ZHAO ; Yang YANG ; Yu-Hang LI ; Bin ZHANG ; Liang-Ding HU
Journal of Experimental Hematology 2023;31(2):522-531
		                        		
		                        			OBJECTIVE:
		                        			To evaluate the efficacy and safety of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with decitabine (Dec)-conditioning regimen in the treatment of myelodysplastic syndrome (MDS) and MDS transformed acute myeloid leukemia (MDS-AML).
		                        		
		                        			METHODS:
		                        			The characteristics and efficacy data of 93 patients with MDS and MDS-AML who received allo-HSCT in our center from April 2013 to November 2021 were retrospectively analyzed. All patients were administered by myeloablative conditioning regimen containing Dec (25 mg/m2 /d×3 d).
		                        		
		                        			RESULTS:
		                        			Among the 93 patients, 63 males and 30 females, were diagnosed as MDS(n =77), MDS-AML(n =16). The incidence of I/II grade regimen-related toxicity (RRT) was 39.8%, and III grade RRT was only found in 1 patient (1%). Neutrophil engraftment was successful in 91 (97.8%) patients after a median neutrophil engraftment time of 14 (9-27) days; Successful platelet engraftment was achieved in 87 (93.5%) patients, with a median engraftment time of 18 (9-290) days. The incidence of acute graft versus host disease(aGVHD) and grade III-IV aGVHD was 44.2% and 16.2%, respectively. The incidence of chronic graft versus host disease(cGVHD) and moderate-to-severe cGVHD was 59.5% and 37.1%, respectively. Of the 93 patients, 54 (58%) developed posttransplant infections, among which lung infection (32.3%) and bloodstream infection (12.9%) were the most common. The median follow-up after transplantation was 45 (0.1-108) months. The 5-year overall survival (OS) rate, disease-free survival (DFS) rate, treatment-related mortality, and cumulative incidence of relapse were 72.7%, 68.4%, 25.1%, and 6.5%, respectively. And the 1-year graft-versus-host disease/relapse-free survival rate was 49.3%. The patients in different group of relative high-risk prognostic scoring or low-risk prognostic scoring, with or without poor-risk mutation(s), with mutations number ≥3 or <3 had similar 5-year OS rate (more than 70%). Multivariate analysis showed that the incidence of grade III-IV aGVHD was the independent risk factor affecting OS(P =0.008)and DFS (P =0.019).
		                        		
		                        			CONCLUSION
		                        			Allo-HSCT with Dec-conditioning regimen is feasible and effective in the treatment of patients with MDS and MDS-AML, especially those in high prognostic risk and with poor-risk mutations.
		                        		
		                        		
		                        		
		                        			Male
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Decitabine
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Transplantation, Homologous/adverse effects*
		                        			;
		                        		
		                        			Transplantation Conditioning/adverse effects*
		                        			;
		                        		
		                        			Myelodysplastic Syndromes/complications*
		                        			;
		                        		
		                        			Leukemia, Myeloid, Acute/therapy*
		                        			;
		                        		
		                        			Hematopoietic Stem Cell Transplantation/adverse effects*
		                        			;
		                        		
		                        			Chronic Disease
		                        			;
		                        		
		                        			Graft vs Host Disease/therapy*
		                        			;
		                        		
		                        			Recurrence
		                        			
		                        		
		                        	
		                				3.The role of γ -aminobutyric acid in tumor immunity
		                			
		                			Lu QIAO ; Min XIAO ; Jia-chun JIANG ; Guo-hui WAN
Acta Pharmaceutica Sinica 2023;58(8):2120-2129
		                        		
		                        			
		                        			 italic>γ-Aminobutyric acid (GABA) is a crucial inhibitory neurotransmitter found in various cells in the human body. While the GABAergic system is typically associated with the nervous system, recent research has revealed that immune cells and tumor cells also express components of this system. In the tumor microenvironment (TME), GABA is secreted to act extracellularly on other cells. GABA is metabolized 
		                        		
		                        	
5.Management experience of a designated hospital for children with coronavirus disease 2019.
Jian-Guo ZHOU ; Qiao-Ling FAN ; Chun-Mei LU ; Pu XU ; Gang-Feng YAN ; Ling-Feng CHUNYU ; Ya-Zun LIU ; Yi-Wei CHEN ; Yan-Ming LU ; Ting ZHANG ; Hui YU ; Li-Bo WANG ; Jiang-Jiang XU ; Wen-Hao ZHOU
Chinese Journal of Contemporary Pediatrics 2022;24(8):839-845
		                        		
		                        			
		                        			The global pandemic of coronavirus disease 2019 (COVID-19) has brought great challenges to the traditional medical model. During the outbreak of COVID-19 in Shanghai, China, from March to May, 2022, there was a significant increase in the number of pediatric cases due to high transmissibility, immune escape, and vaccine breakthrough capacity of Omicron variants. The designated hospitals for children with COVID-19 served as a connecting link between children's specialized hospitals and mobile cabin hospitals. From April 7 to June 2, 2022, a total of 871 children with COVID-19 were admitted to Renji Hospital, Shanghai Jiao Tong University School of Medicine (South Branch), a designated hospital for children with COVID-19. Among these patients, 568 (65.2%) were children under 3 years old, 870 (99.9%) were mild or moderate, and 1 was severe. This article reports the experience in the management of pediatric cases in this designated hospital, which included the following aspects: establishing an optimal case-admission process; strengthening multidisciplinary standardized diagnosis and treatment; optimizing the management, warning, and rescue system for severe COVID-19; implementing family-centered nursing care; formulating an individualized traditional Chinese medicine treatment regimen; optimizing the discharge process and strengthening bed turnover; implementing strict whole-process control to reduce the risk of nosocomial infection; constructing a structured medical record system and using information platforms to adapt to the work mode of large-volume cases; conducting scientific research and sharing the experience in diagnosis and treatment.
		                        		
		                        		
		                        		
		                        			COVID-19
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Hospitals, Pediatric
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			SARS-CoV-2
		                        			
		                        		
		                        	
6.Clonality relatedness and molecular characteristics of Richter transformation
Yeqin SHA ; Rui JIANG ; Yi MIAO ; Tonglu QIU ; Shuchao QIN ; Jingyan QIU ; Hongling MI ; Wei WU ; Chun QIAO ; Yujie WU ; Yi XIA ; Li WANG ; Lei FAN ; Wei XU ; Jianyong LI ; Huayuan ZHU
Chinese Journal of Hematology 2022;43(10):841-847
		                        		
		                        			
		                        			Objective:To investigate the clinical, genetic, and clonality related aspects of individuals with Richter transformation (RT) .Methods:From January 2019 to December 2021, 18 RT patients with diagnoses at the First Affiliated Hospital of Nanjing Medical University (Pukou CLL center) were retrospectively examined. The immunoglobin heavy variable (IGHV) gene usage and IGHV-D-J rearrangement pattern of diagnosed CLL/SLL and transformed diffuse large B-cell lymphoma (DLBCL) were compared to determine the clonality relatedness. To investigate the risk factors of RT, Clinical and laboratory data from patients with newly diagnosed CLL/SLL and transformed DLBCL were gathered.Results:The median age of RT was 56.5 (41-75) years old. 17 patients transformed to DLBCL and 1 transformed to Hodgkin lymphoma (HL) . Of 17 individuals who had DLBCL transformation, 15 had CLL/SLL-related clonality and 2 had unrelated clonality. Next-generation sequencing (NGS) analysis of 11 paired initially diagnosed treatment-naive CLL/SLL and RT DLBCL found that EGR2、TP53 and NOTCH1 were among the most frequently mutated genes both in treatment-naive CLL/SLL and in RT DLBCL. In several cases, specific mutations were gained or lost throughout RT, indicating clonal evolution. Among 10 patients before exposure to BTK inhibitors before RT, four patients acquired BTK mutation. The aforementioned mutations should be considered high-risk variables for transformation; in addition, TP53 and EGR2 mutations could be linked to a poor prognosis following RT in patients receiving a cocktail of new medicines.Conclusion:Most RT DLBCL patients in our center are clonality related (15/17, 88.2% ) and we recommend all qualified centers to evaluate clonality relatedness of RT DLBCL patients. There was some variability in the mutational landscape between DLBCL that had undergone a transformation and initially diagnosed, treatment-naive CLL/SLL. The underlying molecular mechanism of RT needs more research.
		                        		
		                        		
		                        		
		                        	
7.Analysis of Thalassemia Gene Carriers in 19 482 Pregnant Women from 2015 to 2019 in Guilin, Guangxi.
Hai-Qing ZHENG ; Xiang-Yuan YU ; Dan ZENG ; Qiao FENG ; Chun-Jiang ZHU
Journal of Experimental Hematology 2021;29(6):1892-1895
		                        		
		                        			OBJECTIVE:
		                        			To investigate the types and frequencies of thalassemia genes carried by the pregnant women in Guilin, Guangxi Zhuang Autonomous Region, China.
		                        		
		                        			METHODS:
		                        			From January 2015 to December 2019, blood samples of the pregnant women who visited the Outpatients of Obstetrics clinic and Eugenics Genetic clinic in Affiliated Hospital of Guilin Medical University were collected. Gap-PCR was used to detect deletional α-thalassemia, PCR-RDB to detect the gene mutations of non-deletional α-thalassemia and β-thalassemia, and MLPA or DNA sequencing to detect rare thalassemia mutations. Different types and frequencies of thalassemia mutations carried by pregnant women were analyzed statistically.
		                        		
		                        			RESULTS:
		                        			A total of 19 482 blood samples were collected, including 3 801 thalassemia gene carriers (19.51%). Seven types of α-thalassemia gene mutation were detected with a carrier rate of 15.43%. Among them, --
		                        		
		                        			CONCLUSION
		                        			Guilin is a high-risk area for thalassemia. Alpha-thalassemia is dominated by --
		                        		
		                        		
		                        		
		                        			China
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Heterozygote
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Pregnant Women
		                        			;
		                        		
		                        			alpha-Thalassemia/genetics*
		                        			
		                        		
		                        	
8. Relationship between DEAD-box helicase 5, transcription factor 12 and amyotrophic lateral sclerosis
Bao-Yong LIN ; Jin-Chao XU ; Han-Tao YING ; Bao-Yong LIN ; Jin-Chao XU ; Han-Tao YING ; Xin JIANG ; Huan-Cai LIU ; Qing WANG ; Qiao-Zhen WANG ; Yan-Chun CHEN ; Yan-Chun CHEN
Acta Anatomica Sinica 2021;52(5):698-705
		                        		
		                        			
		                        			 Objective To explore the relationship between the expression of DEAO-box helicase 5(DDX5) and transcription factor 12(TCF12) with amyotrophic lateral sclerosis ( ALS ) hippocampal lesions by detecting the expressions and the interaction of DDX5 and TCF12 in the hippocampus of SOD1-G93A mutant ALS transgenic mice. Methods Forty- two pairs of SOD1-G93A mutant ALS transgenic mice and wild-type mice were divided into three groups at the age of 95 days (early onset stage), 108 days (middle onset stage) and 122 days (late onset stage). RT-PCR, Western blotting and double immunofluorescence labeled technique were used to detect the expressions of DDX5 and TCF12 in the hippocampus. Co-immunoprecipitation assasy was used to detect the interaction between DDX5 and TCF12. Results Compared with the wild-type mice of the same age, DDX5 and TCF12 mRNA in the hippocampus of SOD1-G93A mutant ALS transgenic mice were unchanged, but DDX5 and TCF12 protein were up-regulated significantly at day 95, 108 and 122. DDX5 and TCF12 positive cells were found in both DG area and hippocampus proper, and DDX5 and TCF12 were co-localized with neurons. The immunoreactivities of DDX5 and TCF12 in the hippocampus of SOD1-G93A mutant transgenic mice were elevated compared with wild-type mice at the same time point. Co-immunoprecipitation assasys confirmed that there existed interactions between DDX5 and TCF12 protein. Conclusion DDX5 and TCF12 protein are up-regulated in the hippocampal tissues of SOD1-G93A mutant ALS transgenic mice. The abnormal expressions of DDX5 and TCF12 are involved in the hippocampal lesions of ALS. 
		                        		
		                        		
		                        		
		                        	
9.Advances on mechanism and treatment of salivary gland in radiation injury.
Shen-Sui LI ; Chen-Zhou WU ; Xiang-He QIAO ; Chun-Jie LI ; Long-Jiang LI
West China Journal of Stomatology 2021;39(1):99-104
		                        		
		                        			
		                        			Oral squamous cell carcinoma (OSCC) is the most frequent tumour in head and neck malignant. The current treatment is mainly based on surgery therapy, radiation therapy and chemical therapy. Meanwhile, there are many a defect in the treatment. For example, there are many defects in radiotherapy. Radioactive salivatitis is the most common. In addition, there are a series of changes such as dry mouth, oral mucositis, rampant dental caries, and radioactive osteomyelitis of jaw, which cause swallowing, chewing problems, and taste dysfunction. Currently, the research on radioactive salivatitis is progressing rapidly, but its mechanism is more complication. This paper review aims to summarize the research progress in this field.
		                        		
		                        		
		                        		
		                        			Carcinoma, Squamous Cell
		                        			;
		                        		
		                        			Dental Caries
		                        			;
		                        		
		                        			Head and Neck Neoplasms/radiotherapy*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mouth Neoplasms
		                        			;
		                        		
		                        			Radiation Injuries
		                        			;
		                        		
		                        			Salivary Glands
		                        			;
		                        		
		                        			Xerostomia/etiology*
		                        			
		                        		
		                        	
10.Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis.
Jing-Yu CHEN ; Kun QIAO ; Feng LIU ; Bo WU ; Xin XU ; Guo-Qing JIAO ; Rong-Guo LU ; Hui-Xing LI ; Jin ZHAO ; Jian HUANG ; Yi YANG ; Xiao-Jie LU ; Jia-Shu LI ; Shu-Yun JIANG ; Da-Peng WANG ; Chun-Xiao HU ; Gui-Long WANG ; Dong-Xiao HUANG ; Guo-Hui JIAO ; Dong WEI ; Shu-Gao YE ; Jian-An HUANG ; Li ZHOU ; Xiao-Qin ZHANG ; Jian-Xing HE
Chinese Medical Journal 2020;133(12):1390-1396
		                        		
		                        			BACKGROUND:
		                        			Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.
		                        		
		                        			METHODS:
		                        			From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of more than one month and extremely high sequential organ failure assessment scores.
		                        		
		                        			RESULTS:
		                        			Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.
		                        		
		                        			CONCLUSIONS
		                        			LT can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction that could contraindicate LT, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Betacoronavirus
		                        			;
		                        		
		                        			Coronavirus Infections
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			mortality
		                        			;
		                        		
		                        			Extracorporeal Membrane Oxygenation
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung Transplantation
		                        			;
		                        		
		                        			methods
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Pandemics
		                        			;
		                        		
		                        			Pneumonia, Viral
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			mortality
		                        			;
		                        		
		                        			Pulmonary Fibrosis
		                        			;
		                        		
		                        			mortality
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Respiratory Distress Syndrome, Adult
		                        			;
		                        		
		                        			mortality
		                        			;
		                        		
		                        			surgery
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail